{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-049436","form_type":"8-K","ticker":"CGEM","cik":"0001789972","company_name":"Cullinan Therapeutics, Inc.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.129301+00:00","generated_at":"2026-06-03T05:40:57.089556+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cullinan Therapeutics hires Mary Kay Fenton as CFO; $495k salary, 200k-share option grant","bullets":["Mary Kay Fenton appointed CFO effective April 29, 2024; previously CFO of Talaris Therapeutics.","Annual base salary set at $495,000; target annual bonus of 40% of base salary.","Received option to purchase 200,000 shares vesting over 4 years (25% one-year cliff).","Severance: 9 months base salary plus prorated bonus if terminated without cause or for good reason outside CIC period.","No familial relationship with directors/officers; at-will employment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-049436","json":"https://secwatch.observer/filing/0000950170-24-049436.json","markdown":"https://secwatch.observer/filing/0000950170-24-049436.md","text":"https://secwatch.observer/filing/0000950170-24-049436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024049436/0000950170-24-049436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024049436/cgem-20240429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:40:57.089556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"140aa04d19","claim":"Mary Kay Fenton was appointed as Chief Financial Officer at Cullinan Therapeutics, Inc..","evidence_excerpt":"On April 29, 2024, Cullinan Therapeutics, Inc. (the “Company”) announced the hiring and appointment of Mary Kay Fenton as the Company’s Chief Financial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024049436/0000950170-24-049436-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}